Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: PRO

Daniel W. Coyne

doi:10.34067/KID.0002442021

Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: PRO

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	208-210
Number of pages	3
Journal	Kidney360
Volume	3
Issue number	2
DOIs	https://doi.org/10.34067/KID.0002442021
State	Published - Feb 1 2022

Keywords

debate
dialysis
ferryl iron
hemodialysis
iron
mortality

Access to Document

10.34067/KID.0002442021

Cite this

@article{e509d17ab10149ba919b5e8f2a9fd99d,

title = "Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: PRO",

keywords = "debate, dialysis, ferryl iron, hemodialysis, iron, mortality",

author = "Coyne, \{Daniel W.\}",

year = "2022",

month = feb,

day = "1",

doi = "10.34067/KID.0002442021",

language = "English",

volume = "3",

pages = "208--210",

journal = "Kidney360",

issn = "2641-7650",

number = "2",

}

TY - JOUR

T1 - Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients

T2 - PRO

AU - Coyne, Daniel W.

PY - 2022/2/1

Y1 - 2022/2/1

KW - debate

KW - dialysis

KW - ferryl iron

KW - hemodialysis

KW - iron

KW - mortality

UR - https://www.scopus.com/pages/publications/85162814154

U2 - 10.34067/KID.0002442021

DO - 10.34067/KID.0002442021

M3 - Article

C2 - 35373137

AN - SCOPUS:85162814154

SN - 2641-7650

VL - 3

SP - 208

EP - 210

JO - Kidney360

JF - Kidney360

IS - 2

ER -

Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: PRO

Keywords

Access to Document

Other files and links

Cite this